FindTrial
Sign In

HBI0101 CART

BIOLOGICAL2 trials

Sponsors

Polina Stepensky

Conditions

Antiphospholipid Antibody SyndromeIdiopathic Inflammatory Myopathy (IIM)Light Chain AmyloidosisMultiple Myeloma, Refractory to Standard TreatmentMultiple Myeloma, RelapsedMultiple Sclerosis (MS) Primary ProgressiveMultiple Sclerosis (MS) Secondary ProgressiveMyasthenia Gravis (MG)

Phase 1

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
RecruitingNCT07085676
Polina StepenskyAntiphospholipid Antibody Syndrome, Idiopathic Inflammatory Myopathy (IIM), Multiple Sclerosis (MS) Primary Progressive +6
Start: 2024-09-01End: 2030-11-01Target: 120Updated: 2026-05-06

Phase 2

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis
RecruitingNCT06971380
Polina StepenskyLight Chain Amyloidosis, Multiple Myeloma, Refractory to Standard Treatment, Multiple Myeloma, Relapsed
Start: 2025-03-01End: 2030-05-15Target: 180Updated: 2025-05-14